Themis Medicare

{
  "main_header": {
    "sid": 469937,
    "name": "Themis Medicare",
    "stock_name": "Themis Medicare",
    "full_name": "Themis Medicare Ltd",
    "name_url": "stocks-analysis/themis-medicare",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "116.81",
    "chg": -1.29,
    "chgp": "-1.09%",
    "dir": -1,
    "prev_price": "118.10",
    "mcapval": "1,075.82 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530199,
    "symbol": "THEMISMED",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE083B01024",
    "curr_date": "Sep 25, 11:32 AM",
    "curr_time": "11:51 AM",
    "last_traded_at": "Sep 25, 11:32 AM IST",
    "bse_nse_vol": "43.85 k",
    "exc_status": "Active",
    "traded_date": "Sep 25, 2026",
    "traded_date_str": "2026 09 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/themis-medicare-469937-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Themis Medicare Ltd Quality Parameters Show Mixed Signals Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/themis-medicare-ltd-quality-parameters-show-mixed-signals-amid-sector-challenges-4198928",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ThemisMedicareL_qualitydot_4198928.png",
        "date": "2026-09-21 08:00:07",
        "description": "Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its quality grade upgraded from below average to average as of 7 September 2026. Despite this positive shift, the company’s fundamentals present a complex picture with improvements in some areas counterbalanced by persistent challenges in others. This article analyses the key financial metrics and business quality parameters to provide a comprehensive view of Themis Medicare’s current standing and outlook."
      },
      {
        "title": "Themis Medicare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/themis-medicare-ltd-is-rated-sell-4198761",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ThemisMedicareL_mojoScore_4198761.png",
        "date": "2026-09-20 10:10:17",
        "description": "Themis Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 September 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Themis Medicare Gains 6.09%: Technical Upgrades Drive Weekly Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/themis-medicare-gains-609-technical-upgrades-drive-weekly-outperformance-4191615",
        "imagepath": "",
        "date": "2026-09-12 16:04:34",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>7 Sep:</strong> Stock surges 10.41% to ₹133.15 on technical upgrade announcement</p>\n                    <p><strong>8 Sep:</strong> Technical momentum confirmed with bullish indicators and stable price</p>\n                    <p><strong>9 Sep:</strong> Price holds steady at ₹132.25 amid declining market sentiment</p>\n                    <p><strong>10 Sep:</strong> Minor dip to ₹132.00 as volume tapers</p>\n                    <p><strong>11 Sep:</strong> Week closes at ₹127.95, down 3.07% on final session</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹120.6..."
      },
      {
        "title": "Themis Medicare Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/themis-medicare-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-4185979",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ThemisMedicareL_mojoScore_4185979.png",
        "date": "2026-09-08 08:46:52",
        "description": "Themis Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a marked improvement in technical indicators, even as its fundamental financial performance remains under pressure. This nuanced change reflects a complex interplay of quality, valuation, financial trend, and technical factors that investors should carefully consider."
      },
      {
        "title": "Themis Medicare Ltd Sees Bullish Momentum Shift Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/themis-medicare-ltd-sees-bullish-momentum-shift-amid-technical-upgrades-4185563",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ThemisMedicareL_technicaldot_4185563.png",
        "date": "2026-09-08 08:03:16",
        "description": "Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, signalling a transition from a mildly bullish to a more confident bullish trend. This change is underscored by a strong 10.41% surge in the stock price on 8 Sep 2026, reflecting renewed investor interest and positive technical indicators across multiple timeframes."
      },
      {
        "title": "Themis Medicare Ltd Falls 4.29%: Downgrade and Mixed Technicals Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/themis-medicare-ltd-falls-429-downgrade-and-mixed-technicals-shape-the-week-4183907",
        "imagepath": "",
        "date": "2026-09-05 17:09:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>31 Aug:</strong> Stock opens at Rs.124.25, down 1.39%</p>\n                    <p><strong>1 Sep:</strong> Downgrade to Strong Sell announced; price slips to Rs.123.80</p>\n                    <p><strong>2 Sep:</strong> Technical momentum shifts amid mixed signals; stock marginally up to Rs.124.10</p>\n                    <p><strong>4 Sep:</strong> Sharp decline to Rs.120.60, closing the week lower by 4.29%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.126.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><di..."
      },
      {
        "title": "Themis Medicare Ltd Downgraded to Strong Sell Amid Financial and Technical Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/themis-medicare-ltd-downgraded-to-strong-sell-amid-financial-and-technical-concerns-4178964",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ThemisMedicareL_mojoScore_4178964.png",
        "date": "2026-09-02 08:30:55",
        "description": "Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 September 2026. This shift reflects a complex interplay of deteriorating financial fundamentals, challenging valuation metrics, and nuanced technical indicators, despite the company’s recent market-beating stock performance."
      },
      {
        "title": "Themis Medicare Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/themis-medicare-ltd-technical-momentum-shifts-amid-mixed-market-signals-4178502",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ThemisMedicareL_technicaldot_4178502.png",
        "date": "2026-09-02 08:03:33",
        "description": "Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators. Despite a recent downgrade in its Mojo Grade to a Strong Sell, the stock’s price action and technical parameters reveal a cautiously optimistic outlook amid mixed signals from key momentum indicators."
      },
      {
        "title": "Themis Medicare Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/themis-medicare-ltd-is-rated-sell-by-marketsmojo-4173250",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ThemisMedicareL_mojoScore_4173250.png",
        "date": "2026-08-28 10:11:16",
        "description": "Themis Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 28 August 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 330,
    "sid": "469937",
    "stock_news_url": "https://www.marketsmojo.com/news/themis-medicare-469937"
  },
  "announcements": [
    {
      "details": "Themis Medicare Limited has informed the Exchange regarding 'Newspaper Advertisement for Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2019.'.",
      "source": "NSE",
      "caption": "Themis Medicare Limited - Updates",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Themis Medicare Limited has informed the Exchange regarding Grant of 20000 Options under 'Themis Medicare ESOS 2012'.",
      "source": "NSE",
      "caption": "Themis Medicare Limited - ESOP/ESOS/ESPS",
      "datetime": "15-Nov-2019"
    },
    {
      "details": "Themis Medicare Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2019.'.",
      "source": "NSE",
      "caption": "Themis Medicare Limited - Updates",
      "datetime": "18-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Themis Medicare Ltd has declared <strong>50%</strong> dividend, ex-date: 23 Sep 26",
          "dt": "2026-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Themis Medicare Ltd has announced <strong>1:10</strong> stock split, ex-date: 10 Oct 23",
          "dt": "2023-10-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Themis Medicare Ltd Quality Parameters Show Mixed Signals Amid Sector Challenges

2026-09-21 08:00:07

Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its quality grade upgraded from below average to average as of 7 September 2026. Despite this positive shift, the company’s fundamentals present a complex picture with improvements in some areas counterbalanced by persistent challenges in others. This article analyses the key financial metrics and business quality parameters to provide a comprehensive view of Themis Medicare’s current standing and outlook.

Read full news article

Themis Medicare Ltd is Rated Sell

2026-09-20 10:10:17

Themis Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 September 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Themis Medicare Gains 6.09%: Technical Upgrades Drive Weekly Outperformance

2026-09-12 16:04:34

Key Events This Week

7 Sep: Stock surges 10.41% to ₹133.15 on technical upgrade announcement

8 Sep: Technical momentum confirmed with bullish indicators and stable price

9 Sep: Price holds steady at ₹132.25 amid declining market sentiment

10 Sep: Minor dip to ₹132.00 as volume tapers

11 Sep: Week closes at ₹127.95, down 3.07% on final session

Week Open

₹120.6...

Read full news article

Themis Medicare Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-09-08 08:46:52

Themis Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a marked improvement in technical indicators, even as its fundamental financial performance remains under pressure. This nuanced change reflects a complex interplay of quality, valuation, financial trend, and technical factors that investors should carefully consider.

Read full news article

Themis Medicare Ltd Sees Bullish Momentum Shift Amid Technical Upgrades

2026-09-08 08:03:16

Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, signalling a transition from a mildly bullish to a more confident bullish trend. This change is underscored by a strong 10.41% surge in the stock price on 8 Sep 2026, reflecting renewed investor interest and positive technical indicators across multiple timeframes.

Read full news article

Themis Medicare Ltd Falls 4.29%: Downgrade and Mixed Technicals Shape the Week

2026-09-05 17:09:46

Key Events This Week

31 Aug: Stock opens at Rs.124.25, down 1.39%

1 Sep: Downgrade to Strong Sell announced; price slips to Rs.123.80

2 Sep: Technical momentum shifts amid mixed signals; stock marginally up to Rs.124.10

4 Sep: Sharp decline to Rs.120.60, closing the week lower by 4.29%

Week Open

Rs.126.00

Week Close

Read full news article

Themis Medicare Ltd Downgraded to Strong Sell Amid Financial and Technical Concerns

2026-09-02 08:30:55

Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 September 2026. This shift reflects a complex interplay of deteriorating financial fundamentals, challenging valuation metrics, and nuanced technical indicators, despite the company’s recent market-beating stock performance.

Read full news article

Themis Medicare Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-09-02 08:03:33

Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators. Despite a recent downgrade in its Mojo Grade to a Strong Sell, the stock’s price action and technical parameters reveal a cautiously optimistic outlook amid mixed signals from key momentum indicators.

Read full news article

Themis Medicare Ltd is Rated Sell by MarketsMOJO

2026-08-28 10:11:16

Themis Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 28 August 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News